Accuracy of Artificial Intelligence in Evaluation of the Relationship Between Mandibular Third Molar and Mandibular Canal on CBCT
Launched by CAIRO UNIVERSITY · Apr 22, 2022
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
The mandibular third molar extraction, considered one of the most common surgeries in oral and maxillofacial field, it can be associated with several postoperative complications, like pain, bleeding, swelling, and inferior alveolar nerve (IAN) injury or complete damage, impairing the quality of life of the affected patients. The incidence of temporary IAN injury caused by mandibular third molar extraction was 0.4-8.4%, while the incidence of permanent injury is less than 1% \[1, 2\]. However, due to the high occurrence of impacted mandibular third molar, a large number of patients suffer fr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • CBCT Scans showing Mandibular third molar of patients aging from 25 to 65 years old
- • The FOV should clearly show the third molar completely with its roots and the IAN.
- • Voxel size of 0.2mm.
- • Mandibular third molars. Absence of artifacts, dental implants in the adjacent teeth.
- Exclusion Criteria:
- • • CBCT images of sub-optimal quality or artifacts/high scatter interfering with proper assessment.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Enas Anter
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials